Citigroup Inc. boosted its stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 78.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 377,924 shares of the biotechnology company’s stock after buying an additional 166,608 shares during the period. Citigroup Inc. owned approximately […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings. Insider & Institutional Ownership 33.4% of Anavex Life […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $7.68, but opened at $8.00. Anavex Life Sciences shares last traded at $7.88, with a volume of 120,328 shares traded. Analyst Upgrades and Downgrades Several equities research analysts recently […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 15,900,000 shares, a growth of 10.6% from the April 30th total of 14,380,000 shares. Based on an average trading volume of 1,000,000 shares, the days-to-cover ratio […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 15,900,000 shares, an increase of 10.6% from the April 30th total of 14,380,000 shares. Based on an average daily trading volume, of 1,000,000 shares, the days-to-cover ratio is currently […]